Cyclerion Therapeutics Cash Flow Statement (2019-2025) | CYCN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -32.25M-27.32M-26.05M-20.23M-19.53M-21.69M-19.23M-13.39M-16.18M-11.29M-14.34M-12.98M-13.43M-6.09M-2.89M-7.04M-4.24M13.47M-1.62M-1.38M-1.46M-1.67M-1.01M
Share-based Compensation 3.99M6.22M4.95M4.47M4.04M3.95M3.80M3.21M2.31M2.34M2.41M2.55M1.77M1.70M1.66M1.12M0.43M0.38M0.16M0.10M0.18M0.18M0.14M0.12M0.11M0.11M0.12M
Gains from Sales and Divestitures 0.02M0.02M0.06M0.22M0.07M0.07M0.09M0.14M0.04M0.04M0.05M0.05M0.01M0.00M0.04M0.11M0.03M0.04M0.06M0.07M0.02M0.03M0.05M
Gains from Investment Securities -0.01M6.82M6.91M-0.68M0.52M0.33M0.13M-1.87M0.45M0.45M0.45M0.45M0.38M-0.09M0.01M0.01M0.07M0.07M0.33M0.31M0.32M
Asset Writedowns and Impairment 3.30M
Non-cash Items 2.20M29.40M0.53M1.18M0.20M0.20M0.20M0.20M0.10M0.10M0.02M0.10M0.00M0.26M0.25M
Cash from Operations -34.27M-21.97M-23.81M-22.16M-29.18M-14.22M-15.05M-14.04M-14.46M-5.51M-7.92M-8.63M-12.84M-10.82M-9.91M-7.04M-6.21M-6.55M-6.93M-1.54M-1.87M-1.11M-1.72M0.36M-0.97M-0.50M-0.26M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.53M0.80M0.70M0.65M0.63M0.60M0.60M0.47M0.26M0.10M0.60M0.05M0.05M0.02M
Change in Working Capital
Change in Receivables -0.42M0.03M-0.45M-0.28M-0.35M2.42M-0.13M0.28M-0.28M0.13M-0.13M-0.10M0.56M0.03M-0.06M-0.42M
Change in Account Payables 2.89M0.68M-1.62M-2.27M-1.03M1.32M-1.39M-0.21M-0.29M0.96M0.69M0.25M-1.12M1.32M0.95M-2.06M-1.05M0.39M-0.46M-0.09M0.02M0.09M0.09M-0.02M0.02M
Change in Accured Expenses -5.27M1.46M0.28M1.98M-4.71M0.55M0.49M1.69M-3.44M-0.48M-0.14M-0.28M-0.47M-0.11M0.24M-0.19M-0.38M0.46M-1.30M-0.37M-0.19M-0.08M-0.21M-0.04M0.12M-0.14M0.09M
Other Working Capital Changes 0.06M1.80M1.53M-0.74M-0.70M-0.64M-0.66M-0.69M-0.77M-0.27M-0.21M0.01M0.08M-0.36M-0.11M0.27M-0.24M0.48M-0.38M-0.22M-0.13M-0.19M0.51M-0.20M-0.17M0.21M-0.08M
Investing Activities
Capital Expenditures 1.81M4.25M0.65M0.17M1.41M0.07M0.01M0.04M
Sales of Property, Plant and Equipment 0.07M0.05M0.01M0.01M1.47M1.46M0.00M
Cash from Investing Activities -1.81M-4.25M-0.55M-0.10M-1.36M-0.07M0.00M1.44M1.46M0.00M-0.01M10.40M
Financing Activities
Cash from Financing Activities 36.09M174.98M0.36M0.14M0.00M3.66M24.27M0.16M0.03M30.63M0.04M0.09M0.02M0.01M1.38M-0.13M1.83M
Additional items
Exchange Rate Effect -0.00M0.01M-0.02M0.00M-0.01M0.00M0.00M0.00M-0.00M-0.00M-0.00M0.01M0.00M0.00M0.00M-0.00M-0.00M
Change in Cash 148.76M-24.00M-22.14M-30.53M-10.63M9.22M-12.45M-12.97M25.12M-7.89M-8.54M-12.84M-10.80M-9.92M-7.02M-6.21M-1.53M3.47M-1.54M-1.88M-1.11M-1.72M0.36M0.41M-0.63M1.56M
Free Cash Flow -36.09M-26.22M-24.46M-22.34M-30.59M-14.30M-15.06M-14.08M-14.46M-5.51M-7.92M-8.63M-12.84M-10.82M-9.91M-7.04M-6.21M-6.55M-6.93M-1.54M-1.87M-1.11M-1.72M0.36M-0.97M-0.50M-0.26M
Net Cash Flow 148.76M-24.00M-22.12M-30.54M-10.62M9.22M-12.45M-12.97M25.12M-7.89M-8.54M-12.84M-10.80M-9.91M-7.03M-6.21M-6.55M3.47M-1.54M-1.87M-1.11M-1.72M0.36M0.41M-0.63M1.56M